The combination of ribavirin and ozeltamivir effectively inhibits reproduction of influenza a virus resistant to rimantadine (Amantadine) in vitro and in vivo

被引:0
|
作者
P. G. Deryabin
G. A. Galegov
I. D. Konstantinova
I. S. Muzyka
A. I. Miroshnikov
D. K. L’vov
机构
[1] Russian Academy of Medical Sciences,Ivanovsky Research Institute of Virology
[2] Russian Academy of Sciences,Shemyakin
来源
关键词
Influenza Virus; Amantadine; Zanamivir; DOKLADY Biochemistry; Rimantadine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:80 / 83
页数:3
相关论文
共 50 条
  • [41] Astragalus polysaccharide enhances immunity and inhibits H9N2 avian influenza virus in vitro and in vivo
    Sanpha Kallon
    Xiaorong Li
    Jun Ji
    Cuiying Chen
    Qianyun Xi
    Shuang Chang
    Chunyi Xue
    Jingyun Ma
    Qingmei Xie
    Youngliang Zhang
    Journal of Animal Science and Biotechnology, 4
  • [42] Astragalus polysaccharide enhances immunity and inhibits H9N2 avian influenza virus in vitro and in vivo
    Sanpha Kallon
    Xiaorong Li
    Jun Ji
    Cuiying Chen
    Qianyun Xi
    Shuang Chang
    Chunyi Xue
    Jingyun Ma
    Qingmei Xie
    Youngliang Zhang
    Journal of Animal Science and Biotechnology, 2013, 4 (04) : 325 - 335
  • [43] Synergistic anti-influenza virus A (H1N1) activities of PM-523 (polyoxometalate) and ribavirin in vitro and in vivo
    Shigeta, S
    Mori, S
    Watanabe, J
    Soeda, S
    Takahashi, K
    Yamase, T
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) : 1423 - 1427
  • [44] Astragalus polysaccharide enhances chickens immunity and inhibits H9N2 avian influenza virus in vitro and in vivo
    Kallon Sanpha
    Xiaorong Li
    Qianyun Xi
    Qingyan Jiang
    Yongliang Zhang
    Qingmei Xie
    畜牧与兽医, 2012, (S1) : 261 - 262
  • [45] Prominent Efficacy of Amantadine against Human Borna Disease Virus Infection In Vitro and In Vivo. Comment on Fink et al. Amantadine Inhibits SARS-CoV-2 In Vitro. Viruses 2021, 13, 539
    Bode, Liv
    Dietrich, Detlef E.
    Spannhuth, Carsten W.
    Ludwig, Hanns
    VIRUSES-BASEL, 2022, 14 (03):
  • [46] An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and-resistant influenza A viruses
    Hu, Yanmei
    Musharrafieh, Rami
    Ma, Chunlong
    Zhang, Jiantao
    Smee, Donald F.
    DeGrado, William F.
    Wang, Jun
    ANTIVIRAL RESEARCH, 2017, 140 : 45 - 54
  • [47] The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants
    Ianevski, Aleksandr
    Froysa, Irene Troen
    Lysvand, Hilde
    Calitz, Carlemi
    Smura, Teemu
    Nilsen, Hans -Johnny Schjelderup
    Hoyer, Erling
    Afset, Jan Egil
    Sridhar, Adithya
    Wolthers, Katja C.
    Zusinaite, Eva
    Tenson, Tanel
    Kurg, Reet
    Oksenych, Valentyn
    Galabov, Angel S.
    Stoyanova, Adelina
    Bjoras, Magnar
    Kainov, Denis E.
    ANTIVIRAL RESEARCH, 2024, 224
  • [48] The NF-KappaB-Inhibitor SC75741 Efficiently Blocks Influenza Virus Propagation In Vitro and In Vivo Without the Tendency to Induce Resistant Virus Variant
    Reiling, Sarah
    Droebner, Karoline
    Ehrhardt, Christina
    Hrincius, Eike Hirinus
    Ludwig, Stephan
    Planz, Oliver
    ANTIVIRAL RESEARCH, 2010, 86 (01) : A43 - A43
  • [49] Taishan Pinus massoniana pollen polysaccharide inhibits H9N2 subtype influenza virus infection both in vitro and in vivo
    Shang, Hongqi
    Sha, Zhou
    Wang, Huan
    Miao, Yongqiang
    Niu, Xiangyun
    Chen, Ruichang
    Huang, Jin
    Huang, He
    Wei, Kai
    Zhu, Ruiliang
    VETERINARY MICROBIOLOGY, 2020, 248
  • [50] The combination of poly(ADP-ribose) polymerase inhibitor and statin inhibits the proliferation of human castration-resistant and taxane-resistant prostate cancer cells in vitro and in vivo
    Sekine, Yoshitaka
    Oka, Daisuke
    Ohtsu, Akira
    Nakayama, Hiroshi
    Miyao, Takeshi
    Miyazawa, Yoshiyuki
    Arai, Seiji
    Koike, Hidekazu
    Matsui, Hiroshi
    Shibata, Yasuhiro
    Suzuki, Kazuhiro
    BMC CANCER, 2025, 25 (01)